KRTAP5-2

gene
On this page

Also known as KRTAP5.2KRTAP5-8

Summary

KRTAP5-2 (keratin associated protein 5-2, HGNC:23597) is a protein-coding gene on chromosome 11p15.5, encoding Keratin-associated protein 5-2 (Q701N4). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linki….

Predicted to be located in cytosol.

Source: NCBI Gene 440021 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 36 total
  • MANE Select transcript: NM_001004325

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23597
Approved symbolKRTAP5-2
Namekeratin associated protein 5-2
Location11p15.5
Locus typegene with protein product
StatusApproved
AliasesKRTAP5.2, KRTAP5-8
Ensembl geneENSG00000205867
Ensembl biotypeprotein_coding
Entrez440021

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000412090

RefSeq mRNA: 1 — MANE Select: NM_001004325 NM_001004325

CCDS: CCDS31331

Canonical transcript exons

ENST00000412090 — 1 exons

ExonStartEnd
ENSE0000166717815971771598294

Expression profiles

Bgee: expression breadth broad, 77 present calls, max score 67.28.

Top tissues by expression

113 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
prefrontal cortexUBERON:000045167.28gold quality
frontal cortexUBERON:000187057.18gold quality
primary visual cortexUBERON:000243654.49gold quality
cerebellumUBERON:000203754.33gold quality
cerebellar hemisphereUBERON:000224554.07gold quality
cerebellar cortexUBERON:000212953.80gold quality
right hemisphere of cerebellumUBERON:001489053.52gold quality
duodenumUBERON:000211448.67gold quality
granulocyteCL:000009448.30silver quality
tonsilUBERON:000237247.46silver quality
mucosa of transverse colonUBERON:000499146.90gold quality
superior frontal gyrusUBERON:000266146.71gold quality
sural nerveUBERON:001548846.47silver quality
cerebral cortexUBERON:000095645.77gold quality
right frontal lobeUBERON:000281043.44gold quality
brainUBERON:000095542.74gold quality
Brodmann (1909) area 9UBERON:001354042.18gold quality
apex of heartUBERON:000209841.75silver quality
gall bladderUBERON:000211040.66gold quality
dorsolateral prefrontal cortexUBERON:000983440.32gold quality
skeletal muscle tissueUBERON:000113440.16silver quality
hypothalamusUBERON:000189839.97gold quality
muscle tissueUBERON:000238539.35silver quality
anterior cingulate cortexUBERON:000983539.15gold quality
nucleus accumbensUBERON:000188237.96gold quality
colonic epitheliumUBERON:000039737.20gold quality
caudate nucleusUBERON:000187337.12gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
putamenUBERON:000187436.26gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

31 targeting KRTAP5-2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4533100.0069.482758
HSA-MIR-12118100.0065.881270
HSA-MIR-453499.9966.581907
HSA-MIR-318599.9968.121959
HSA-MIR-10401-5P99.9965.79948
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-808299.9567.271170
HSA-MIR-464899.9167.00710
HSA-MIR-6764-5P99.7567.892304
HSA-MIR-1915-3P99.5866.791988
HSA-MIR-516B-5P99.5666.331495
HSA-MIR-444199.4966.563216
HSA-MIR-147B-5P99.4570.622432
HSA-MIR-664A-3P99.2271.082696
HSA-MIR-427099.0266.261987
HSA-MIR-5011-3P98.6364.81638
HSA-MIR-6754-5P98.6065.541627
HSA-MIR-1199-5P98.4466.51829
HSA-MIR-6751-3P98.4466.35835
HSA-MIR-4768-3P98.1666.022330
HSA-MIR-211-3P98.1466.771052
HSA-MIR-451898.1266.821030
HSA-MIR-1266-5P97.7166.921052
HSA-MIR-493-3P97.5066.44731
HSA-MIR-1212896.6766.981471
HSA-MIR-1245A96.3366.25498
HSA-MIR-807996.3366.11484
HSA-MIR-139-3P95.2463.10316
HSA-MIR-6750-5P93.9466.68797

Literature-anchored findings (GeneRIF, showing 1)

  • CK7 and Cam 5.2 expression may occur in SCC. A panel including Ber-Ep4 is advisable for immunohistochemical differentiation of EPD from SCC. (PMID:23590728)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusKrtap5-4ENSMUSG00000045236
mus_musculusKrtap5-1ENSMUSG00000066100
mus_musculusKrtap5-5ENSMUSG00000073785
mus_musculusKrtap5-22ENSMUSG00000109655

Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)

Protein

Protein identifiers

Keratin-associated protein 5-2Q701N4 (reviewed: Q701N4)

Alternative names: Keratin-associated protein 5-8, Keratin-associated protein 5.2, Keratin-associated protein 5.8, Ultrahigh sulfur keratin-associated protein 5.2

All UniProt accessions (1): Q701N4

UniProt curated annotations — full annotation on UniProt →

Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.

Subunit / interactions. Interacts with hair keratins.

Tissue specificity. Restricted to hair root, not detected in any other tissues.

Similarity. Belongs to the KRTAP type 5 family.

RefSeq proteins (1): NP_001004325* (*=MANE)

Domains & families (InterPro)

UniProt features (8 total): repeat 6, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q701N4-F139.470.00

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-1266738Developmental Biology

MSigDB gene sets: 47 (showing top): DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, chr11q13, MARTINEZ_RB1_TARGETS_DN, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, LEE_AGING_MUSCLE_UP, DURCHDEWALD_SKIN_CARCINOGENESIS_UP, MULLIGHAN_MLL_SIGNATURE_2_DN, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, MULLIGHAN_MLL_SIGNATURE_1_DN, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, MIKKELSEN_MEF_LCP_WITH_H3K27ME3, FIGUEROA_AML_METHYLATION_CLUSTER_1_DN

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Developmental Biology1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cytoplasm1
cellular anatomical structure1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

114 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRTAP5-2OR6X1Q8NH79166
KRTAP5-2OR6F1Q8NGZ6166
KRTAP5-2ACTR5Q9H9F9102
KRTAP5-2INO80CQ6PI9899
KRTAP5-2K7ENP7K7ENP799
KRTAP5-2RUVBL1P8227690
KRTAP5-2RUVBL2Q9Y23090
KRTAP5-2OR1J4Q8NGS177
KRTAP5-2ACTL6BO9480567
KRTAP5-2ACTR8Q9H98166
KRTAP5-2KRTAP11-1Q8IUC162
KRTAP5-2KRT74Q7RTS753
KRTAP5-2KRT71Q3SY8444
KRTAP5-2FUCA2Q9BTY20
KRTAP5-2NUFIP2Q7Z4170
KRTAP5-2EMC7Q9NPA00
KRTAP5-2CHD5Q8TDI00

IntAct

152 interactions, top by confidence:

ABTypeScore
KRTAP5-2KRTAP9-2psi-mi:“MI:0915”(physical association)0.600
KRTAP5-2LELP1psi-mi:“MI:0915”(physical association)0.560
KRTAP5-2UBE2Ipsi-mi:“MI:0915”(physical association)0.560
LCE3CKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
LCE1EKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
LCE2DKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
LCE2CKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
MEOX2KRTAP5-2psi-mi:“MI:0915”(physical association)0.560
KRTAP5-2LCE1Bpsi-mi:“MI:0915”(physical association)0.560
KRTAP5-2KRTAP4-5psi-mi:“MI:0915”(physical association)0.560
LCE3BKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
KRTAP5-2MACO1psi-mi:“MI:0915”(physical association)0.560
KRTAP10-6KRTAP5-2psi-mi:“MI:0915”(physical association)0.560
KRTAP5-2LMNTD2psi-mi:“MI:0915”(physical association)0.560
OPCMLKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
LCE1FKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
CRY2KRTAP5-2psi-mi:“MI:0915”(physical association)0.560
KRTAP5-2CRCT1psi-mi:“MI:0915”(physical association)0.560
KRTAP5-7KRTAP5-2psi-mi:“MI:0915”(physical association)0.560
KRTAP10-7KRTAP5-2psi-mi:“MI:0915”(physical association)0.560
TACSTD2KRTAP5-2psi-mi:“MI:0915”(physical association)0.560
LCE3EKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
KRTAP5-2DHRS1psi-mi:“MI:0915”(physical association)0.560
KRTAP5-2KRTAP2-4psi-mi:“MI:0915”(physical association)0.560
MT1BKRTAP5-2psi-mi:“MI:0915”(physical association)0.560
KRTAP5-4KRTAP5-2psi-mi:“MI:0915”(physical association)0.560
DLGAP3KRTAP5-2psi-mi:“MI:0915”(physical association)0.560
HOXA1KRTAP5-2psi-mi:“MI:0915”(physical association)0.560

BioGRID (61): KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid), KRTAP5-2 (Two-hybrid)

ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 45 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization2439.3×2e-33
Formation of the cornified envelope1538.8×2e-19

GO biological processes:

GO termPartnersFoldFDR
keratinization1499.3×1e-23

Disease & clinical

Clinical variants and AI predictions

ClinVar

36 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance33
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

777 predictions. Top by Δscore:

VariantEffectΔscore
11:71538228:G:Tdonor_gain0.9700
11:71538501:G:GGdonor_gain0.9700
11:1598083:A:Cdonor_gain0.9600
11:71538498:GCT:Gdonor_gain0.9600
11:1598099:C:Adonor_gain0.9500
11:1598020:G:Cdonor_gain0.9400
11:1598181:A:ATdonor_gain0.9400
11:71538202:C:Gdonor_gain0.9400
11:71538227:G:GTdonor_gain0.9400
11:71538524:GGCT:Gdonor_gain0.9400
11:71538525:GCTG:Gdonor_gain0.9400
11:71538668:G:GTdonor_gain0.9400
11:71538669:A:Tdonor_gain0.9400
11:1598038:TGG:Tdonor_gain0.9200
11:1597509:C:CTacceptor_gain0.9100
11:1597509:C:Tacceptor_gain0.9100
11:1598098:T:TAdonor_gain0.9100
11:71538123:G:Tdonor_gain0.9100
11:1597421:C:Tacceptor_gain0.9000
11:1597994:C:Adonor_gain0.9000
11:1597421:C:CTacceptor_gain0.8900
11:1598055:CGGG:Cdonor_gain0.8900
11:1598224:G:GAdonor_gain0.8900
11:71538750:GGC:Gdonor_gain0.8900
11:1597514:C:CTacceptor_gain0.8800
11:71538123:G:GTdonor_gain0.8700
11:71538437:GGCT:Gdonor_gain0.8700
11:71538438:GCTG:Gdonor_gain0.8700
11:71538727:GAC:Gdonor_gain0.8600
11:1598180:C:CTdonor_gain0.8500

AlphaMissense

1142 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:1597721:A:CI177S0.671
11:1597843:G:CS136R0.627
11:1597843:G:TS136R0.627
11:1597845:T:GS136R0.627
11:1597813:G:CS146R0.620
11:1597813:G:TS146R0.620
11:1597815:T:GS146R0.620
11:1597783:G:CS156R0.617
11:1597783:G:TS156R0.617
11:1597785:T:GS156R0.617
11:1597891:C:AK120N0.603
11:1597891:C:GK120N0.603
11:1597723:C:AK176N0.592
11:1597723:C:GK176N0.592
11:1597721:A:GI177T0.581

dbSNP variants (sampled 300 via entrez): RS1000050507 (11:1599360 A>G), RS1004681179 (11:1597189 C>A,T), RS1005243444 (11:1596975 T>TC), RS1006639209 (11:1600087 C>A,T), RS1006811142 (11:1599154 C>A,T), RS1007169784 (11:1599532 A>G), RS1008194326 (11:1596864 C>A,T), RS1012230484 (11:1599000 A>G), RS1015275259 (11:1597197 G>A), RS1015866895 (11:1598642 T>C), RS1016818572 (11:1599806 C>T), RS1017276425 (11:1600097 G>C,T), RS1019747468 (11:1597846 G>A), RS1019915227 (11:1599190 G>T), RS1021349136 (11:1597286 A>G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

5 total (human), top 5 by PubMed support.

ChemicalActions (top 5)PubMed papers
CGP 52608affects binding, increases reaction1
Leflunomideincreases expression1
Cadmiumincreases expression1
Aflatoxin B1increases methylation1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.